Denali Therapeutics Inc. (DNLI) PT Raised to $53 at Wedbush
Tweet
Share
E-mailGet Alerts DNLI Hot Sheet
Price: $24.35 -0.2%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Wedbush analyst Laura Chico raised the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $53.00 (from $50.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
- Samsonite International SA (1910:HK) (SMSEY) PT Lowered to HK$19.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
